JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, cilt.33, sa.4, ss.304-312, 2017 (SCI-Expanded)
Purpose: To report the efficacy and safety of interferon (IFN) alpha-2a in patients with cystoid macular edema (CME) associated with presumed ocular tuberculosis (TB).